Skip to main content
. 2016 Mar 7;17:123. doi: 10.1186/s13063-016-1248-x

Table 2.

Data collected during PrEvENT

Participant assessment Who When
Usual care team Consultant Research nurse Participant Research team Pre-screening Cohort baseline appointment Surgery Cohort follow-up/true trial baseline appointment 6-month intervention duration 3-month follow-up appointment 6-month follow-up appointment Evaluation interview
Eligibility screening X X X X
Informed consent X X X X
Demographic data X X X X X
Family medical history X X X X X
Anthropometric data weight, height, % body fat X X X X X
Blood sample X X X X
Diet data FFQ [43] X X X X X
Physical activity data Recent Physical Activity Questionnaire [44] X X X X X
Urinary symptoms ICSmale-SF [45] X X X X X
Psychological measures POMS-SF [46] and Benefit Finding Scale [47] X X X X X
Health beliefs data Adapted from [37] and [32] X X X X X
Quality of life measures FACT-P [48] X X X X X
General health data SF-12 [49] X X X X X
Cancer related fatigue FACIT-Fatigue [48] X X X X X
Lifestyle data Drinking and smoking X X X X X
Accelerometry data X X X X
Prostate tissue X X
Pedometer data X X
Daily monitoring data Step count, record of fruit, vegetable, dairy and lycopene intake X X
Qualitative evaluation data X X X